quinazolines has been researched along with amsacrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chilin, A; Dalla Via, L; Guiotto, A; Marzaro, G; Toninello, A | 1 |
| Bhosle, J; Hartley, JA; Hochhauser, D; Kiakos, K; Makris, A; Porter, AC; Wu, J | 1 |
2 other study(ies) available for quinazolines and amsacrine
| Article | Year |
|---|---|
Benzoquinazoline derivatives as new agents affecting DNA processing.
Topics: Amsacrine; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; DNA; HeLa Cells; Humans; Male; Models, Molecular; Quinazolines; Salmon; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2011 |
Treatment with gefitinib or lapatinib induces drug resistance through downregulation of topoisomerase IIα expression.
Topics: Amsacrine; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gefitinib; Gene Expression Regulation, Neoplastic; Histones; Humans; Lapatinib; Protein Kinase Inhibitors; Quinazolines | 2013 |